Pulmonary Edema News and Research

RSS
Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Greater awareness of MH and consequences of ryanodine receptor gene mutations

Greater awareness of MH and consequences of ryanodine receptor gene mutations

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

Merck announces data from ZOSTAVAX Phase III study on shingles

Merck announces data from ZOSTAVAX Phase III study on shingles

Mayo Clinic researchers join expedition to Everest

Mayo Clinic researchers join expedition to Everest

Scientist generates mutant version of IL-2 protein to treat advanced cancers

Scientist generates mutant version of IL-2 protein to treat advanced cancers

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Baxter submits GAMMAGARD LIQUID sBLA to FDA for treatment of MMN

Baxter submits GAMMAGARD LIQUID sBLA to FDA for treatment of MMN

Risk factors for acute mountain sickness

Risk factors for acute mountain sickness

Scientists identify how cells reduce tissue damage from inflammation in ALI model

Scientists identify how cells reduce tissue damage from inflammation in ALI model

Terrorist attacks with chemical weapons are a real possibility: Study

Terrorist attacks with chemical weapons are a real possibility: Study

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Preventive use of ACZ may reduce risk of severe high altitude illness

Preventive use of ACZ may reduce risk of severe high altitude illness

UofL researchers to develop treatments for chlorine-induced lung injuries

UofL researchers to develop treatments for chlorine-induced lung injuries

Researchers awarded $12M to study pathology of severe lung injury

Researchers awarded $12M to study pathology of severe lung injury

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Pregnant women face higher risk of stroke

Pregnant women face higher risk of stroke

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting

Cardioxyl's CXL-1020 preclinical data against heart failure presented at ACC meeting